Q2 2026 Guidance -- Revenue $205 million; gross margin ~43%; operating expenses ~$59 million; adjusted EBITDA ~$34 million; ...
THE 52ND ANNUAL Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held in the highest-altitude ...
Axcelis Technologies, Inc. ( ACLS) Q1 2026 Earnings Call May 7, 2026 5:00 PM EDT Good day, ladies and gentlemen, and welcome to the Axcelis Technologies call to discuss the company's results for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results